Fatal Cholestatic Liver Injury during Treatment with PD1 Immune Checkpoint Inhibitor for Malignant Melanoma: A Case Report

The use of immune checkpoint inhibitors has dramatically improved the chance of surviving malignant melanomas; however, the effect comes at the cost of toxicities that are difficult to predict. Immune-mediated hepatitis is the most common form of liver toxicity, but fatal outcome is uncommon. We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorsteinsdottir, Thuridur, Løitegård, Teje, Reims, Henrik Mikael, Porojnicu, Alina Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383158/
https://www.ncbi.nlm.nih.gov/pubmed/32774252
http://dx.doi.org/10.1159/000507695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383158/
https://www.ncbi.nlm.nih.gov/pubmed/32774252
http://dx.doi.org/10.1159/000507695

Ejemplares similares